ProShares Ultra Nasdaq BiotechnologyLatest ProShares Ultra Nasdaq Biotechnology News and UpdatesCompany & Industry OverviewsBuy Allows Horizon to Further Expand into Orphan Drug SpaceThrough the acquisition of Raptor Pharmaceuticals, Horizon Pharma (HZNP) will gain access to Procysbi and Quinsair and expand in the orphan drug space.
Company & Industry OverviewsBuy Allows Horizon to Further Expand into Orphan Drug SpaceThrough the acquisition of Raptor Pharmaceuticals, Horizon Pharma (HZNP) will gain access to Procysbi and Quinsair and expand in the orphan drug space.